In 2023, Hungary recorded the highest female mortality rate due to trachea, bronchus, or lung malignant neoplasms with 72.1 deaths per 100,000 women. Colombia had one of the lowest rates at 7.7. Over the past year, significant decreases were observed in the United States at -2.49% and Costa Rica at -2.74%, while Bulgaria, Greece, and Spain saw increases over 3%. Over five years, countries like Spain, Bulgaria, and Portugal had substantial growth in mortality rates, suggesting worsening conditions or poor healthcare interventions.
Future trends to watch include technological advancements in early detection, the impact of anti-smoking legislation, and differences in healthcare access across countries. These factors will shape the trajectory of mortality rates in forthcoming years. Close monitoring of regional policy changes and healthcare quality improvements will be crucial in understanding future shifts in mortality rates globally.
Top countries in Trachea, Bronchus or Lung Malignant Neoplasms Mortality by Country
| # | 10 Countries | Units (Female Deaths) Per Hundred Thousand Women | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Hungary | 72.1 | 2023 | +1.41% | +1.72% | View data |
| 2 | 2 Denmark | 57.1 | 2023 | -1.21% | -0.24% | View data |
| 3 | 3 Canada | 50.1 | 2023 | +0.2% | -0.24% | View data |
| 4 | 4 Netherlands | 49.9 | 2023 | -0.2% | -0.4% | View data |
| 5 | 5 Slovenia | 47.9 | 2023 | +2.79% | +1.99% | View data |
| 6 | 6 Croatia | 47.2 | 2023 | +3.28% | +3.03% | View data |
| 7 | 7 United Kingdom | 45 | 2023 | -1.32% | -1.12% | View data |
| 8 | 8 Poland | 43.6 | 2023 | +1.63% | +1.09% | View data |
| 9 | 9 Germany | 41.1 | 2023 | +0.49% | +0.9% | View data |
| 10 | 10 Austria | 39 | 2023 | +1.83% | +2.25% | View data |
